ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy › Research Explorer

DOI

https://doi.org/10.1038/s41389-018-0096-9
Final published version

V. L. Veenstra
H. Damhofer
C. Waasdorp
L. B. van Rijssen
M. J. van de Vijver
F. Dijk
H. W. Wilmink
M. G. Besselink
O. R. Busch
D. K. Chang
P. J. Bailey
A. V. Biankin
H. M. Kocher
J. P. Medema
J. S. Li
R. Jiang
D. W. Pierce
H. W. M. van Laarhoven
M. F. Bijlsma

Original language	English
Article number	87
Journal	Oncogenesis
Volume	7
Issue number	11
DOIs	https://doi.org/10.1038/s41389-018-0096-9
Publication status	Published - 2018

ID: 5717107